France· FR:61829909
WEGOVY 1 mg, FlexTouch solution injectable en stylo prérempli
A medicinal product containing sémaglutide, registered in France by NOVO NORDISK (DANEMARK), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- SÉMAGLUTIDE
- Manufacturer
- NOVO NORDISK (DANEMARK)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009302586441 cartouche en verre de 3 mL dans stylo prérempli + 4 aiguillesEUR 146.91
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sémaglutide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandKayshild 1 mg solution for injection in pre-filled penNovo Nordisk A/S
- NetherlandsKayshild 1 mg oplossing voor injectie in een voorgevulde penNovo Nordisk A.S.
- CzechiaKAYSHILDNovo Nordisk A/S, Bagsvaerd
- United StatesOzempicNovo Nordisk Pharmaceutical Industries, LP
- FinlandKayshildNovo Nordisk A/S
- PolandKayshildNovo Nordisk A/S
- BelgiumKayshild 0.25 mgNovo Nordisk
- SwedenKayshild 0,25 mg Injektionsvätska, lösning i förfylld injektionspennaNovo Nordisk A/S
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Kayshild, Ozempic
- Norway · Kayshild, Ozempic
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ef90ea03-2323-4c74-bbdf-7ce4fc7cc441 GET /v1/drugs/ef90ea03-2323-4c74-bbdf-7ce4fc7cc441?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61829909",
"date_amm": "2023-03-31",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/21/1608",
"substance": "SÉMAGLUTIDE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about sémaglutide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.